Related Experiment Video
Updated: Jun 27, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
A Multi-Omic Huntington's Disease Transgenic Sheep-Model Database for Investigating Disease Pathogenesis
Emily R Mears1, Renee R Handley1, Matthew J Grant1
1Centre for Brain Research, School of Biological Sciences, The University of Auckland, Auckland, New Zealand.
This article introduces a new, publicly accessible web database containing comprehensive biological data from a sheep model of Huntington's disease. By combining transcriptomic, metabolomic, and proteomic information, researchers can now explore disease-related changes across different tissues to better understand how this condition develops.
Area of Science:
- Neuroscience research within the field of multi-omic data integration
- Transgenic animal models of Huntington's disease pathogenesis
Background:
The precise biological pathways driving cellular decline in Huntington's disease remain poorly understood. Prior research has shown that existing models often fail to capture the full complexity of human neurodegeneration. That uncertainty drove the creation of a transgenic sheep model to better mimic clinical progression. Scientists previously lacked a centralized repository to analyze these complex biological signatures effectively. This gap motivated the development of a unified platform for multi-omic data storage. Previous studies focused on isolated molecular layers rather than integrated systems. No prior work had resolved the need for a user-friendly, queryable interface for this specific animal cohort. Researchers now possess a tool to bridge the divide between animal data and human clinical observations.
Purpose Of The Study:
The primary aim is to provide a publicly available database for advancing the discovery of pathogenic mechanisms in Huntington's disease. Researchers sought to address the lack of defined pathways regarding cellular dysfunction and death. This project was motivated by the need to support therapeutic testing using a transgenic sheep model. The team intended to integrate large-scale biological datasets into a single, accessible format. They aimed to enable the wider research community to explore complex molecular profiles efficiently. By creating a queryable platform, they hope to facilitate the validation of findings from patient samples. This effort addresses the challenge of interpreting interrelated data from diverse tissue types. The authors designed this resource to serve as a central hub for future investigations into disease progression.
Main Methods:
Review Approach: The researchers integrated seven distinct datasets derived from a cohort of twelve sheep. They utilized the R programming language to organize these high-throughput transcriptomic, metabolomic, and proteomic measurements. The team designed a web-based platform to host this information for public access. Automated statistical analysis functions were embedded to assist with rapid exploratory inquiries. The design ensures that users can either query the data online or download files for independent processing. Validation involved comparing current database outputs against previously published results from the same animal group. This approach prioritizes user-friendly access for the wider scientific community. The methodology emphasizes transparency and reproducibility in managing large-scale biological information.
Main Results:
Key Findings From the Literature: The database successfully hosts integrated information from six OVT73 transgenic sheep and six control animals. Statistically significant differences in molecular profiles were observed between these two groups. The platform provides comprehensive coverage of transcriptomic, metabolomic, and proteomic data. Researchers can access these findings through a queryable web interface at the provided URL. The system validates the integrity of the data by mirroring previously reported results. Automated functions allow for immediate statistical testing of the uploaded profiles. The repository includes samples collected from both blood and brain tissues. Users can also perform custom analyses by downloading the full datasets for local evaluation.
Conclusions:
The authors propose this web-based platform as a tool for generating new research hypotheses. This resource allows scientists to confirm or refute observations derived from human patient samples. It serves as a method to validate findings across diverse experimental model systems. The database facilitates a deeper understanding of the molecular drivers behind this neurodegenerative condition. By providing open access, the team encourages broader community engagement with the transgenic sheep data. The integrated information supports rapid exploratory analysis through automated statistical functions. Future investigations can utilize the remaining tissue samples from the original cohort. This project provides a foundation for more robust comparative studies in the field.
Frequently Asked Questions
The platform integrates seven distinct datasets, including transcriptomic, metabolomic, and proteomic profiles. Researchers utilize these to compare OVT73 transgenic sheep against control animals, enabling the identification of statistically significant molecular changes across blood and brain tissues.
The team employed the programming language R to construct the queryable web-based interface. This technical choice allows for the inclusion of automated statistical analysis functions, which support rapid exploratory inquiries by users accessing the site.
The researchers focused on a cohort of 5-year-old animals, specifically six OVT73 transgenic sheep and six control subjects. This sample size was selected to ensure the integrity of the multi-omic profiles when compared to previously published findings.
The database functions as a hypothesis generator by allowing users to download raw data or perform online queries. This role enables scientists to cross-reference their own experimental results with the established multi-omic profiles of the OVT73 model.
The platform measures molecular variations across multiple tissues, including blood and brain samples. These measurements allow for the observation of systemic changes that might otherwise be missed in single-tissue studies of neurodegeneration.
The authors suggest that their database will expand the current understanding of disease development. They propose that this resource will help clarify the pathological mechanisms of cellular dysfunction by providing a reliable, shared reference point for the global research community.
More Related Videos
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021